These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 17417639)

  • 41. ESR1-Amplification-Associated Estrogen Receptor α Activity in Breast Cancer.
    Holst F; Singer CF
    Trends Endocrinol Metab; 2016 Nov; 27(11):751-752. PubMed ID: 27595547
    [No Abstract]   [Full Text] [Related]  

  • 42. R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers.
    Boldes T; Merenbakh-Lamin K; Journo S; Shachar E; Lipson D; Yeheskel A; Pasmanik-Chor M; Rubinek T; Wolf I
    BMC Cancer; 2020 Jun; 20(1):531. PubMed ID: 32513126
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab: A Secondary Analysis of the HERA Trial.
    Loi S; Dafni U; Karlis D; Polydoropoulou V; Young BM; Willis S; Long B; de Azambuja E; Sotiriou C; Viale G; Rüschoff J; Piccart MJ; Dowsett M; Michiels S; Leyland-Jones B
    JAMA Oncol; 2016 Aug; 2(8):1040-7. PubMed ID: 27100299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Amplification of the TOP2A gene does not predict high levels of topoisomerase II alpha protein in human breast tumor samples.
    Mueller RE; Parkes RK; Andrulis I; O'Malley FP
    Genes Chromosomes Cancer; 2004 Apr; 39(4):288-97. PubMed ID: 14978790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Amplification and overexpression of the ABCC3 (MRP3) gene in primary breast cancer.
    Partanen L; Staaf J; Tanner M; Tuominen VJ; Borg Å; Isola J
    Genes Chromosomes Cancer; 2012 Sep; 51(9):832-40. PubMed ID: 22585709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The promoter C specific ERalpha isoform is associated with tamoxifen outcome in breast cancer.
    Amaral S; Schroth W; Kugler S; Fritz P; Simon W; Brauch H
    Breast Cancer Res Treat; 2009 Nov; 118(2):323-31. PubMed ID: 19011961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retrospective analysis of estrogen receptor 1 and N‑acetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell lines.
    Carlisle SM; Hein DW
    Int J Oncol; 2018 Aug; 53(2):694-702. PubMed ID: 29901116
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Copy number analysis of c-erb-B2 (HER-2/neu) and topoisomerase IIalpha genes in breast carcinoma by quantitative real-time polymerase chain reaction using hybridization probes and fluorescence in situ hybridization.
    Murthy SK; Magliocco AM; Demetrick DJ
    Arch Pathol Lab Med; 2005 Jan; 129(1):39-46. PubMed ID: 15628907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A multiplex allele-specific real-time PCR assay for screening of ESR1 mutations in metastatic breast cancer.
    Wang T; Liu JH; Zhang J; Wang L; Chen C; Dai PG
    Exp Mol Pathol; 2015 Apr; 98(2):152-7. PubMed ID: 25746663
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models.
    Bahreini A; Li Z; Wang P; Levine KM; Tasdemir N; Cao L; Weir HM; Puhalla SL; Davidson NE; Stern AM; Chu D; Park BH; Lee AV; Oesterreich S
    Breast Cancer Res; 2017 May; 19(1):60. PubMed ID: 28535794
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved Risk Stratification for Breast Cancer Samples Based on the Expression Ratio of the Estrogen and Progesterone Receptor.
    Bendrat K; Fritz P; Müller S; Brockmöller S; Debus A; Friedrichs K; Lindner C; Brinkmann F; Heidemann E; Niendorf A
    Anticancer Res; 2016 Aug; 36(8):3855-63. PubMed ID: 27466487
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer.
    Bailey SD; Desai K; Kron KJ; Mazrooei P; Sinnott-Armstrong NA; Treloar AE; Dowar M; Thu KL; Cescon DW; Silvester J; Yang SY; Wu X; Pezo RC; Haibe-Kains B; Mak TW; Bedard PL; Pugh TJ; Sallari RC; Lupien M
    Nat Genet; 2016 Oct; 48(10):1260-6. PubMed ID: 27571262
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neo-tanshinlactone selectively inhibits the proliferation of estrogen receptor positive breast cancer cells through transcriptional down-regulation of estrogen receptor alpha.
    Lin W; Huang J; Liao X; Yuan Z; Feng S; Xie Y; Ma W
    Pharmacol Res; 2016 Sep; 111():849-858. PubMed ID: 27491559
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estrogen receptor alpha (ESR1) mutant A908G is not a common feature in benign and malignant proliferations of the breast.
    Tebbit CL; Bentley RC; Olson JA; Marks JR
    Genes Chromosomes Cancer; 2004 May; 40(1):51-4. PubMed ID: 15034868
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epigenetic Changes of the ESR1 Gene in Breast Tissue of Healthy Women: A Missing Link with Breast Cancer Risk Factors?
    Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Bastami M; Tavakkoly-Bazzaz J
    Genet Test Mol Biomarkers; 2017 Aug; 21(8):464-470. PubMed ID: 28708432
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of estrogen receptor α on the tamoxifen response and prognosis in luminal-A-like and luminal-B-like breast cancer.
    Babyshkina N; Vtorushin S; Dronova T; Patalyak S; Slonimskaya E; Kzhyshkowska J; Cherdyntseva N; Choynzonov E
    Clin Exp Med; 2019 Nov; 19(4):547-556. PubMed ID: 31562548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Estrogen receptor (ER) mRNA and ER-related gene expression in breast cancers that are 1% to 10% ER-positive by immunohistochemistry.
    Iwamoto T; Booser D; Valero V; Murray JL; Koenig K; Esteva FJ; Ueno NT; Zhang J; Shi W; Qi Y; Matsuoka J; Yang EJ; Hortobagyi GN; Hatzis C; Symmans WF; Pusztai L
    J Clin Oncol; 2012 Mar; 30(7):729-34. PubMed ID: 22291085
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer.
    Stone A; Zotenko E; Locke WJ; Korbie D; Millar EK; Pidsley R; Stirzaker C; Graham P; Trau M; Musgrove EA; Nicholson RI; Gee JM; Clark SJ
    Nat Commun; 2015 Jul; 6():7758. PubMed ID: 26169690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential association of ESR1 and ESR2 gene variants with the risk of breast cancer and associated features: A case-control study.
    Ghali RM; Al-Mutawa MA; Al-Ansari AK; Zaied S; Bhiri H; Mahjoub T; Almawi WY
    Gene; 2018 Apr; 651():194-199. PubMed ID: 29414691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
    Mrhalová M; Kodet R; Strnad P
    Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.